OVARIAN-CARCINOMA - A REVIEW OF THE SIGNIFICANCE OF FAMILIAL RISK-FACTORS AND THE ROLE OF PROPHYLACTIC OOPHORECTOMY IN CANCER PREVENTION

被引:0
|
作者
NGUYEN, HN [1 ]
AVERETTE, HE [1 ]
JANICEK, M [1 ]
机构
[1] DIV GYNECOL ONCOL, MIAMI, FL USA
关键词
OVARIAN CANCER; FAMILY HISTORY; HEREDITARY CANCER SYNDROME; PROPHYLACTIC OOPHORECTOMY;
D O I
10.1002/1097-0142(19940715)74:2<545::AID-CNCR2820740204>3.0.CO;2-Q
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Women with a family history of ovarian cancer are at increased risk of ovarian cancer. Prophylactic oophorectomy(PO) remains the only effective method of ovarian cancer prevention. This study reviewed current data on the significance of family history and how prophylactic oophorectomy should be used in different risk groups. Approximately 7% of ovarian cancer patients have a positive family history of whom 3-9% may eventually manifest certain hereditary cancer syndromes. Women in direct genetic lineage of family cancer syndromes have up to a 50% lifetime risk of ovarian cancer. Because of the high risk, PO is indicated for women with familial cancer syndromes after childbearing or between the ages of 35-40 at the latest. The majority of women with a positive family history of ovarian cancer do not have one of the recognized syndromes. Women with one or two affected relatives have an increased lifetime risk of ovarian cancer from a baseline of 1.6 to 5-7%. This risk is not high enough to warrant PO for a large number of women. After being properly informed, the patient still chooses surgical prevention, she then receives PO. For women without a family history of ovarian cancer, the role of PO remains controversial. Assuming an annual incidence of 22,000 new cases of ovarian cancer, it is estimated that at least 1000 may be prevented if PO is diligently practiced during hysterectomy. Despite ovarian and breast cancer prevention, PO would lead to shorter life expectancy if estrogen therapy compliance were less than perfect. Thus, the decision on PO as a concurrent procedure should depend on the individual patient and her ability to comply with lifelong estrogen therapy.
引用
收藏
页码:545 / 555
页数:11
相关论文
共 47 条
  • [41] The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis
    Ye, Lu
    Cai, Li
    Fu, Yonghui
    Zhuang, Debao
    Hu, Xiaoqing
    Jie, Youkun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [42] The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis
    Lu Ye
    Li Cai
    Yonghui Fu
    Debao Zhuang
    Xiaoqing Hu
    Youkun Jie
    World Journal of Surgical Oncology, 19
  • [43] The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection
    Patel, Swati G.
    Karlitz, Jordan J.
    Yen, Timothy
    Lieu, Christopher H.
    Boland, C. Richard
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (03): : 262 - 274
  • [44] Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
    Almansour, Nahlah Makki
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [45] Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis
    Yu, Hailin
    Wang, Jieyu
    Wu, Beibei
    li, Jun
    Chen, Ruifang
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [46] Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis
    Hailin Yu
    Jieyu Wang
    Beibei Wu
    Jun li
    Ruifang Chen
    Journal of Ovarian Research, 16
  • [47] Surgery for Recurrent Ovarian Cancer: Role of Peritoneal Carcinomatosis: Exploratory Analysis of the DESKTOP I Trial About Risk Factors, Surgical Implications, and Prognostic Value of Peritoneal Carcinomatosis
    P. Harter
    M. Hahmann
    H. J. Lueck
    M. Poelcher
    P. Wimberger
    O. Ortmann
    U. Canzler
    B. Richter
    U. Wagner
    A. Hasenburg
    A. Burges
    S. Loibl
    W. Meier
    J. Huober
    D. Fink
    W. Schroeder
    K. Muenstedt
    B. Schmalfeldt
    G. Emons
    A. du Bois
    Annals of Surgical Oncology, 2009, 16 : 1324 - 1330